Axicabtagene Ciloleucel Side Effects

Axicabtagene Ciloleucel, as a type of CAR-T cell therapy, has significant therapeutic effects, but it is also accompanied by a series of potential side effects. These side effects mainly originate from immune response and activation of CAR-T cells, as well as other treatment-related factors. Here are some common and serious side effects that may occur with Aquilenza:

1. Cytokine release syndrome (CRS):

CRSis a common side effect that may occur within days ofCAR-T cell therapy. It originates from the release of a large amount of cytokines after activation of CAR-T cells, leading to a systemic inflammatory response. CRSThe symptoms include: fever, chills, headache, muscle or joint pain, low blood pressure, heart palpitations, shortness of breath, etc.

The severity of CRScan vary from individual to individual, with cases ranging from mild symptoms to severe disease and even the need for intensive care reported.

2. Nervous system toxicity:

Some patients may experience neurological toxicity, manifested by the following symptoms: dizziness, consciousness disorder, headache, aphasia, deafness, loss of consciousness, etc.

Nervous system toxicity may be temporary but may persist for a longer period of time in some cases. Early monitoring and treatment are key.

3. Persistently low blood cell count:

Akilenza may cause a decrease in the count of white blood cells, red blood cells, and platelets, called cytopenias. This can lead to anemia, infection, and bleeding tendencies.

4. Acidosis and abnormal renal function:

Some patients may develop acidosis and abnormal kidney function due to metabolites produced by cell breakdown. These situations need to be dealt with promptly.

5. Infection:

BecauseCAR-Tcell therapy suppresses the immune system, patients are more susceptible to infections. Infection is a potentially serious risk that requires close monitoring and management.

6. Long-term effects:

It is unclearthe long-term effects of CAR-Tcell therapy, including possible long-term side effects and the risk of secondary malignancies after treatment.

7. Allergic reaction:

Some patients may have an allergic reaction to the drugs used in the treatment or ingredients in the preparation.

It is important to emphasize that the side effects of Akilenza vary from patient to patient, and the severity of side effects also varies from individual to individual. Therefore, close monitoring and medical management are critical for patients treated with Aquilenza to promptly manage and minimize the risk of side effects. Patients should learn more about treatment options, discuss potential risks and benefits, and receive treatment under professional medical supervision before deciding to undergo treatment. Medical professionals will manage and mitigate side effects on a patient-specific basis.